Professor of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School
Pediatric Hematology & Oncology
Dr. Eva C. Guinan, MD
|
|
Give Review
Doctor Eva C. Guinan, MD is an expert in the field of Pediatric Hematology & Oncology. She attended Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine She has 3 awards "America's Top Doctors for Cancer", "Boston Magazine" and "America's Top Doctors". Guinan is also a published physician. She has 38 publication published. The most recent publication is: Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
Publications
- Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
- Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.
- Prize-based contests can provide solutions to computational biology problems.
- Changing factors associated with parent activation after pediatric hematopoietic stem cell transplant.
- Serum Citrulline As A Biomarker of Gastrointestinal Function During Hematopoietic Cell Transplantation (HCT) in Children.
- Effect of Weight on Outcomes of Children Undergoing Hematopoietic Cell Transplantation.
- Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients.
- Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicent...
- Factors Associated With Parental Activation in Pediatric Hematopoietic Stem Cell Transplant.
- Bactericidal/Permeability-Increasing Protein (rBPI21) and Fluoroquinolone Mitigate Radiation-Induced Bone Marrow Aplasia and Death.
- 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.
- Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease.
- Diagnosis and management of aplastic Anemia.
- Therapy for aplastic Anemia.
- Induction of alloantigen-specific anergy in human peripheral blood mononuclear cells by alloantigen stimulation with co-stimulatory signal blockade.
- Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding ...
- Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.
- A multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantat...
- Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation.
- Acquired aplastic Anemia in childhood.
- Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematolog...
- Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.
- Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies.
- Weekly measurements accurately represent trends in resting energy expenditure in children undergoing hematopoietic stem cell transplantation.
- Prognostic factors in the resumption of oral dietary intake after allogeneic hematopoietic stem cell transplantation (HSCT) in children.
- Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.
- Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.
- Contribution of bone marrow-derived endothelial cells to human tumor vasculature.
- Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
- Aplastic Anemia: management of pediatric patients.
- Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature.
- A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation.
- Autoantibodies frequently detected in patients with aplastic Anemia.
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
- Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.
- Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response withou...
- Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils.
Schools
Harvard Medical School
Children39s Hospital
Dana Farber Cancer Institute
Conditions Treated
- Anemia
- Non-Hodgkin's Lymphoma
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors for Cancer
- Boston Magazine
- America's Top Doctors
Education
-
Boston Children's Hospital -
Harvard Medical School
Hospital
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Dana-Farber Cancer Institute
Helpful Reviews
Similar Doctors
|
|
Dr. Raffaele Renella, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Mullen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupama Narla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan N. Chi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathrin M. Bernt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Crompton, MD
This Doctor is OpenDoctor Recommended.
|